GURUFOCUS.COM » STOCK LIST » Consumer Cyclical » Retail - Cyclical » Trilogy AI Corp (FRA:Y920) » Definitions » Sloan Ratio %

Trilogy AI (FRA:Y920) Sloan Ratio % : 0.00% (As of Jun. 2024)


View and export this data going back to 2022. Start your Free Trial

What is Trilogy AI Sloan Ratio %?

Richard Sloan from the University of Michigan was first to document what is referred to as the "accrual anomaly". His 1996 paper found that shares of companies with small or negative accruals vastly outperform (+10%) those of companies with large ones.

Trilogy AI's Sloan Ratio for the quarter that ended in Jun. 2024 was 0.00%.

As of Jun. 2024, Trilogy AI has a Sloan Ratio of 0.00%, indicating the company is in the safe zone and there is no funny business with accruals.


Trilogy AI Sloan Ratio % Historical Data

The historical data trend for Trilogy AI's Sloan Ratio % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Trilogy AI Sloan Ratio % Chart

Trilogy AI Annual Data
Trend Dec21 Dec22 Dec23
Sloan Ratio %
23.36 - -

Trilogy AI Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24
Sloan Ratio % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Trilogy AI's Sloan Ratio %

For the Specialty Retail subindustry, Trilogy AI's Sloan Ratio %, along with its competitors' market caps and Sloan Ratio % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Trilogy AI's Sloan Ratio % Distribution in the Retail - Cyclical Industry

For the Retail - Cyclical industry and Consumer Cyclical sector, Trilogy AI's Sloan Ratio % distribution charts can be found below:

* The bar in red indicates where Trilogy AI's Sloan Ratio % falls into.



Trilogy AI Sloan Ratio % Calculation

Earnings contain a lot of non cash earnings which is called accruals. The Sloan ratio is a way to identify firms with low non-cash or accrual-derived earnings relative to their cash flow.

Trilogy AI's Sloan Ratio for the fiscal year that ended in Dec. 2023 is calculated as

Sloan Ratio=(Net Income (A: Dec. 2023 )-Cash Flow from Operations (A: Dec. 2023 )
-Cash Flow from Investing (A: Dec. 2023 ))/Total Assets (A: Dec. 2023 )
=(-1.718--1.254
-0)/0.422
=-109.95%

Trilogy AI's Sloan Ratio for the quarter that ended in Jun. 2024 is calculated as

Sloan Ratio=(Net Income (TTM)-Cash Flow from Operations (TTM))
-Cash Flow from Investing (TTM))/Total Assets (Q: Jun. 2024 )
=(-1.739--1.322
-0)/0.119
=-350.42%

Trilogy AI's Net Income for the trailing twelve months (TTM) ended in Jun. 2024 was -0.755 (Sep. 2023 ) + -0.709 (Dec. 2023 ) + -0.142 (Mar. 2024 ) + -0.133 (Jun. 2024 ) = €-1.74 Mil.
Trilogy AI's Cash Flow from Operations for the trailing twelve months (TTM) ended in Jun. 2024 was -0.816 (Sep. 2023 ) + -0.211 (Dec. 2023 ) + -0.107 (Mar. 2024 ) + -0.188 (Jun. 2024 ) = €-1.32 Mil.
Trilogy AI's Cash Flow from Investing for the trailing twelve months (TTM) ended in Jun. 2024 was 0 (Sep. 2023 ) + 0 (Dec. 2023 ) + 0 (Mar. 2024 ) + 0 (Jun. 2024 ) = €0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Trilogy AI  (FRA:Y920) Sloan Ratio % Explanation

A former University of Michigan researcher, Richard Sloan's 1996 paper found that shares of companies with small or negative accruals vastly outperform (+10%) those of companies with large ones. In fact, for the 40-year period between 1962 and 2001, buying the lowest accrual companies and shorting the highest accrual companies resulted in an average annual compounded return of 18%, more than double the S&P 500's 7.4% annual return over the same period.

According to How to Beat the Market with the Sloan Ratio:

If the Sloan Ratio is between -10% and 10%, the company is in the safe zone and there is no funny business with accruals.

If the Sloan Ratio is less than between -25% and -10% on the negative side, and between 10% and 25% on the positive side, this is a warning stage of accrual build up.

If the Sloan Ratio is less than -25% or greater than 25%, and this ratio is consistent over several quarters or even years, be careful. Earnings are highly likely to be made up of accruals.

As of Jun. 2024, Trilogy AI has a Sloan Ratio of 0.00%, indicating the company is in the safe zone and there is no funny business with accruals.


Trilogy AI Sloan Ratio % Related Terms

Thank you for viewing the detailed overview of Trilogy AI's Sloan Ratio % provided by GuruFocus.com. Please click on the following links to see related term pages.


Trilogy AI Business Description

Traded in Other Exchanges
Address
905 West Pender Street, 6th Floor, Vancouver, BC, CAN, V6C 1L6
Ambari Brands Incy is an emerging cosmetic company. It is a luxury, performance-driven skincare company, whose line of products is based on its customized Blend, which combines high levels of active ingredients, smart adaptogens, and broad-spectrum CBD. The firm has developed three core products - the Gold Profection22 Mask, the PM Active12 Serum and the Complex4 Hydrator Cream. The company's products are currently sold directly through its e-commerce platform, as well as through select luxury retailers online.

Trilogy AI Headlines

No Headlines